VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Infanrix/Hib
Vaccine Information
  • Vaccine Name: Infanrix/Hib
  • Target Pathogen: Bordetella pertussis
  • Target Disease: Whooping Cough
  • Product Name: Combined diphtheria, tetanus, acellular pertussis (DTPa) and Haemophilus influenza type b vaccine
  • Tradename: Infanrix/Hib
  • Manufacturer: GlaxoSmithKline
  • Vaccine Ontology ID: VO_0010720
  • Type: Subunit vaccine
  • Status: Licensed
  • Location Licensed: Canada
  • Host Species for Licensed Use: Human
  • Adjuvant:
  • Preservative: 2 phenoxy ethanol
  • Allergen: Latex in plunger stopper of prefilled syringe
  • Immunization Route: Intramuscular injection (i.m.)
  • Storage: Refrigerated stored between +2°C and +8°C.
  • Approved Age for Licensed Use: 15 months and older
  • Description: Products: Proteins + conjugate. Other components: Formaldehyde, Lactose.
Host Response
References